{"title":"Endemic Mycoses and COVID-19: a Review","authors":"F. Messina, G. Giusiano, G. Santiso","doi":"10.1007/s12281-022-00435-z","DOIUrl":"https://doi.org/10.1007/s12281-022-00435-z","url":null,"abstract":"","PeriodicalId":10813,"journal":{"name":"Current Fungal Infection Reports","volume":"16 1","pages":"98 - 106"},"PeriodicalIF":1.4,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48368796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Evolving Landscape of Diagnostics for Invasive Fungal Infections in Lung Transplant Recipients","authors":"T. Marinelli, S. V. van Hal","doi":"10.1007/s12281-022-00433-1","DOIUrl":"https://doi.org/10.1007/s12281-022-00433-1","url":null,"abstract":"","PeriodicalId":10813,"journal":{"name":"Current Fungal Infection Reports","volume":"16 1","pages":"75 - 86"},"PeriodicalIF":1.4,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41788005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mucormycosis in Solid Organ Transplant","authors":"Alejandro Perez Davila, C. Spak, E. Dominguez","doi":"10.1007/s12281-022-00431-3","DOIUrl":"https://doi.org/10.1007/s12281-022-00431-3","url":null,"abstract":"","PeriodicalId":10813,"journal":{"name":"Current Fungal Infection Reports","volume":"16 1","pages":"70-73"},"PeriodicalIF":1.4,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44100715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Azole Therapeutic Drug Monitoring and its Use in the Management of Invasive Fungal Disease","authors":"Aadith Ashok, R. P. Mangalore, C. Morrissey","doi":"10.1007/s12281-022-00430-4","DOIUrl":"https://doi.org/10.1007/s12281-022-00430-4","url":null,"abstract":"","PeriodicalId":10813,"journal":{"name":"Current Fungal Infection Reports","volume":"16 1","pages":"55 - 69"},"PeriodicalIF":1.4,"publicationDate":"2022-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49541384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D. Palacios-Reyes, Á. Costta-Michuy, Tania M. Vargas-Vázquez, M. V. Martínez-Astudillo, Rafael Oscar Santamaría Vásquez, N. Aguilar-Gómez, Astrid A. Hernandez-Soto, Sofía Fortes-Gutiérrez, Daniel Reyes-Gutierrez, Dania J. Juárez-Padilla, Silvia Fuentes-Soliz
{"title":"Central Nervous System Fungal Infections in Paediatric Patients","authors":"D. Palacios-Reyes, Á. Costta-Michuy, Tania M. Vargas-Vázquez, M. V. Martínez-Astudillo, Rafael Oscar Santamaría Vásquez, N. Aguilar-Gómez, Astrid A. Hernandez-Soto, Sofía Fortes-Gutiérrez, Daniel Reyes-Gutierrez, Dania J. Juárez-Padilla, Silvia Fuentes-Soliz","doi":"10.1007/s12281-021-00427-5","DOIUrl":"https://doi.org/10.1007/s12281-021-00427-5","url":null,"abstract":"","PeriodicalId":10813,"journal":{"name":"Current Fungal Infection Reports","volume":"1 1","pages":"1-16"},"PeriodicalIF":1.4,"publicationDate":"2022-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49597081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Overview of COVID-19-Associated Invasive Fungal Infection.","authors":"Akira A Shishido, Minu Mathew, John W Baddley","doi":"10.1007/s12281-022-00434-0","DOIUrl":"10.1007/s12281-022-00434-0","url":null,"abstract":"<p><strong>Purpose of review: </strong>Invasive fungal infections are a complication of COVID-19 disease. This article reviews literature characterizing invasive fungal infections associated with COVID-19.</p><p><strong>Recent findings: </strong>Multiple invasive fungal infections including aspergillosis, candidiasis, pneumocystosis, other non-<i>Aspergillus</i> molds, and endemic fungi have been reported in patients with COVID-19. Risk factors for COVID-19-associated fungal disease include underlying lung disease, diabetes, steroid or immunomodulator use, leukopenia, and malignancy. COVID-19-associated pulmonary aspergillosis (CAPA) and COVID-19-associated mucormycosis (CAM) are the most common fungal infections described. However, there is variability in the reported incidences related to use of differing diagnostic algorithms.</p><p><strong>Summary: </strong>Fungal pathogens are important cause of infection in patients with COVID-19, and the diagnostic strategies continue to evolve. Mortality in these patients is increased, and providers should operate with a high index of suspicion. Further studies will be required to elucidate the associations and pathogenesis of these diseases and best management and prevention strategies.</p>","PeriodicalId":10813,"journal":{"name":"Current Fungal Infection Reports","volume":"16 3","pages":"87-97"},"PeriodicalIF":2.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40600194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why.","authors":"Bishan Radotra, Sundaram Challa","doi":"10.1007/s12281-022-00443-z","DOIUrl":"10.1007/s12281-022-00443-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>There is global increase in the incidence of mucormycosis. However, a sudden increase in the COVID-associated mucormycosis (CAM) was noted, particularly in India, during the second wave of the COVID-19 pandemic. The interplay of factors involved in the pathogenesis is complex. In this review, the influence of pre-existing disease, exaggerated risk factors, altered milieu due to COVID-19 itself and the consequences of its treatment on the host pathogen interactions leading to the disease and morphology of the fungus will be highlighted.</p><p><strong>Recent findings: </strong>Hyperglycemia, acidosis, available free iron, lowered host defenses, and the fungal virulence factors promote the growth of Mucorales. There is a high background prevalence of diabetes mellitus (DM) in India. Uncontrolled or undiagnosed DM, COVID-19 itself, and inappropriate administration of corticosteroids in high doses and for prolonged periods result in hyperglycemia. Diabetic ketoacidosis (DKA) and metabolic acidosis due to hypoxia or renal failure contribute to acidic pH and dissociate bound iron from serum proteins. The host defenses are lowered due to COVID-19-induced immune dysregulation, hyperglycemia itself, and administration of corticosteroids and immune suppressants for the treatment of COVID-19. The altered metabolic milieu in the local microenvironment of nose and paranasal sinuses (PNS) promotes specific interaction of glucose-regulated protein-78 (GRP-78) on host cells with spore coat protein homologue (CotH 3) on Mucorales resulting in rhino-orbito-cerebral mucormycosis (ROCM) as the predominant clinical form in CAM. The pathology is extensive soft tissue involvement with angioinvasion and perineural invasion. Melanized hyphae and sporangia were seen on histopathology, which is unique to CAM. While many factors favor the growth of Mucorales in CAM, hyperglycemia, hyperferritinemia, and administration of hyperbaric oxygen result in reactive oxygen species (ROS) and inadequate humidification results in dehydration. Melanization is possibly the adaptive and protective mechanism of Mucorales to escape the unfavorable conditions due to the treatment of COVID-19.</p><p><strong>Summary: </strong>High background prevalence of DM, inappropriate administration of corticosteroids and immune dysregulation due to COVID-19 favor the growth of Mucorales in CAM. Melanization of Mucorales hyphae and sporangia on histopathology probably represent adaptive and protective mechanism due to the treatment with hyperbaric oxygen with inadequate humidification as well as the metabolic alterations.</p>","PeriodicalId":10813,"journal":{"name":"Current Fungal Infection Reports","volume":"16 4","pages":"206-220"},"PeriodicalIF":2.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33487533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vahid Reza Ostovan, Reza Tabrizi, Hanieh Bazrafshan, Zahra Bahrami, Hajar Khazraei, Samaneh Khazraei, Afshin Borhani-Haghighi, Mohsen Moghadami, Matthew Grant
{"title":"Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: a systematic review and meta-analysis.","authors":"Vahid Reza Ostovan, Reza Tabrizi, Hanieh Bazrafshan, Zahra Bahrami, Hajar Khazraei, Samaneh Khazraei, Afshin Borhani-Haghighi, Mohsen Moghadami, Matthew Grant","doi":"10.1007/s12281-022-00440-2","DOIUrl":"https://doi.org/10.1007/s12281-022-00440-2","url":null,"abstract":"<p><strong>Purpose of review: </strong>Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) can increase the susceptibility of individuals to contracting mucormycosis through several mechanisms. Nowadays, coronavirus disease (COVID-19)-associated mucormycosis (CAM) is a serious public health concern, particularly in developing countries. This meta-analysis aims to identify the risk factors that affect the mortality rate of patients with CAM.</p><p><strong>Recent findings: </strong>We systematically searched PubMed, Google Scholar, Scopus, Cochrane library, and preprint databases using pertinent keywords and the reference lists of the included relevant articles from inception till October 27, 2021. In order to reduce the effects of small-scale studies, we only selected cross-sectional, case-control, and cohort studies and case series with at least four patients. We identified 26 articles that included 821 patients with CAM. The effect size (ES) of mortality rate was 28% (95% confidence interval (CI) 20%-38%; I<sup>2</sup> =82.28%; p for Cochran Q<0.001). The CAM patients with a history of comorbidities other than diabetes (malignancies, transplant, or renal failure), mechanical ventilation due to COVID-19, pulmonary and cerebral mucormycosis, and those who only received medical treatment for mucormycosis had the highest mortality rate.</p><p><strong>Summary: </strong>Coronavirus disease (COVID-19)-associated mucormycosis (CAM) is a major public health problem, particularly in developing countries. Severe COVID-19 infection, history of mechanical ventilation, early CAM, comorbidities other than diabetes (malignancies, transplant, or renal failure), pulmonary and rhino-orbito-cerebral mucormycosis, and delivering only medical treatment for mucormycosis were the worst prognostic factors in CAM patients. Identifying the mortality-related risk factors in CAM patients may help reduce the mortality rate by implementing optimized treatment approaches.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12281-022-00440-2.</p>","PeriodicalId":10813,"journal":{"name":"Current Fungal Infection Reports","volume":" ","pages":"143-153"},"PeriodicalIF":1.4,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40617132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}